Corvus Pharmaceuticals, Inc. | ||||
NGM : CRVS || Location: United States | ||||
$1.78-0.01 (-0.56%) |
0.27 M | 1.76 - 1.85 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 1.494 M |
Feb. 29, 2024 | 1.273 M |
Feb. 15, 2024 | 1.274 M |
Jan. 31, 2024 | 1.378 M |
Jan. 12, 2024 | 1.399 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.12 | -0.14 | -15.32% |
09/30/2023 | -0.12 | -0.12 | 3.54% |
06/30/2023 | -0.14 | -0.14 | 1.41% |
03/31/2023 | -0.16 | -0.17 | -6.18% |
12/31/2022 | -0.24 | -0.21 | 10.87% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 49.039M | Shares Float | 34.398M |
Short Float | 1.494M | Market Cap | 87.78M |
Institution ownership | 39.97% | Insider ownership | 3.887% |
Earnings Date | 05/06/2024 AMC | Cash Per Share | ? |
Trailing EPS | -0.56 | Forward EPS | -0.61 |